The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of hypertension and proteinuria with overall survival in solid-tumor patients treated with anti-VEGF drugs in the MARS study.
Vincent Launay-Vacher
Research Funding - Amgen; Bayer Schering Pharma; Boehringer Ingelheim; Celgene; Daiichi Sankyo; Fresenius Biotech; Gilead Sciences; Ipsen; Janssen-Cilag; LEO Pharma
Nicolas Janus
Consultant or Advisory Role - Pfizer
Honoraria - Fresenius Biotech; Roche
Isabelle Laure Ray-Coquard
Consultant or Advisory Role - PharmaMar; Roche
Research Funding - PharmaMar; Roche
Philippe Beuzeboc
No relevant relationships to disclose
Catherine Daniel
No relevant relationships to disclose
Joseph Gligorov
Consultant or Advisory Role - Roche; Teva
Frédéric Selle
No relevant relationships to disclose
Francois Goldwasser
Consultant or Advisory Role - Roche
Honoraria - Roche
Olivier Mir
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche; SERVIER
Research Funding - Pfizer
Jean-Philippe Spano
Consultant or Advisory Role - Amgen; Cephalon; GlaxoSmithKline; LEO Pharma; Merck Serono; MSD; Roche; Sanofi ; Teva
Jean Christophe Thery
No relevant relationships to disclose
Jean-Baptiste Rey
Honoraria - Amgen; Archimedes; Baxter ; B-Braun; Boehringer Ingelheim; Bristol-Myers Squibb; Fresenius Kabi; Helsinn Healthcare; Idis; LEO Pharma; Merck; Merck Serono; Mundipharma; Pfizer; Roche; Sandoz
Christelle Jouannaud
No relevant relationships to disclose
Jean F. Morere
No relevant relationships to disclose
Stephane Oudard
Honoraria - Bayer; Novartis; Pfizer; Sanofi
Florian Scotte
No relevant relationships to disclose
Michel Azizi
No relevant relationships to disclose
Richard Dorent
No relevant relationships to disclose
Gilbert Deray
No relevant relationships to disclose